Physician profile
Logan Easterday
NPI 1528635356
$7,448.36
in general payments reported to CMS, 2019-2025
42 companies · $1,289 in 2025
The $1,289 reported for 2025 was more than what 90% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $912 · 2022: $1,775 · 2023: $1,920 · 2024: $1,552 · 2025: $1,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,761.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $952.89 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $775.28 | 2021-2025 | Erleada, Akeega |
| Pfizer INC. | $760.26 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $529.38 | 2021-2025 | Prolaris |
| Axonics, INC. | $402.69 | 2021-2024 | Axonics |
| Myovant Sciences INC. | $298.55 | 2021-2022 | |
| Abbvie INC. | $292.48 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $271.16 | 2023-2025 | Urgent Pc Neuromodulation System |
| Endo Pharmaceuticals INC. | $265.90 | 2021-2022 | |
| Urogen Pharma, INC. | $250.43 | 2021-2025 | Jelmyto |
| Antares Pharma, INC. | $241.61 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $241.01 | 2021-2024 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $221.52 | 2022-2025 | Axonics, Rezum Generator |
| Rochester Medical Corporation | $210.27 | 2021-2022 | |
| Urovant Sciences INC | $160.21 | 2021-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $149.83 | 2021-2024 | |
| Medtronic, INC. | $145.28 | 2021-2024 | Interstim |
| Tolmar Pharmaceuticals, INC. | $120.38 | 2021-2022 | |
| Srs Medical Systems, INC. | $107.16 | 2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Verity Pharmaceuticals INC. | $105.65 | 2023-2025 | Tlando, Trelstar |
| Merck Sharp & Dohme LLC | $96.83 | 2022-2024 | Keytruda, Lynparza, Welireg |
| Progenics Pharmaceuticals, INC. | $86.09 | 2022-2023 | Pylarify |
| Tolmar, INC. | $73.79 | 2023 | |
| 180 Medical, INC. | $69.55 | 2021-2023 | |
| Valencia Technologies Corporation | $63.39 | 2025 | Ecoin Device Kit |
| Convatec INC. | $63.13 | 2022-2023 | |
| Angiodynamics, INC. | $60.33 | 2021-2023 | Nanoknife |
| Ferring Pharmaceuticals INC. | $60.19 | 2024-2025 | Adstiladrin |
| Coloplast Corp | $57.64 | 2023 | Speedicath |
| Procept Biorobotics Corporation | $51.05 | 2024 | Aquabeam System |
| Halozyme INC | $34.59 | 2023 | |
| Allergan, INC. | $32.77 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $27.83 | 2023 | Seglentis |
| Accord Healthcare, INC. | $27.62 | 2022 | |
| Azurity Pharmaceuticals, INC. | $25.57 | 2025 | Azmiro |
| Ambu INC. | $20.94 | 2024 | |
| Hollister Incorporated | $20.92 | 2023 | Vapro Pocket |
| Olympus America INC. | $17.13 | 2023 | Itind System |
| Clarus Therapeutics INC. | $16.84 | 2021 | |
| Novo Nordisk INC | $14.92 | 2024 | |
| Profound Medical Corp. | $13.07 | 2022 | |
| Rti Surgical, INC | $12.23 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Easterday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.